Henlius und Dr. Reddy’s unterzeichnen Lizenzvertrag für HLX15 (Daratumumab-Biosimilar) zur Expansion in Europa und den USA

Posted on by

SHANGHAI, 7. Februar 2025 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) meldete heute die Unterzeichnung einer Lizenzvereinbarung mit Dr. Reddy’s Laboratories SA, einer hundertprozentigen Tochtergesellschaft von Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE:…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.